Abstract
Scleromyxedema is an unusual skin disease that is characterized by a proliferation of fibroblasts and an accumulation of mucin. Despite experience with multiple forms of therapy, no single agent has proved uniformly beneficial in this condition. We describe a patient with scleromyxedema who was treated successfully with 2-chlorodeoxyadenosine (2-CdA), a purine analog used mainly in the treatment of lymphoproliferative disorders.
Original language | English (US) |
---|---|
Pages (from-to) | 288-290 |
Number of pages | 3 |
Journal | Journal of the American Academy of Dermatology |
Volume | 35 |
Issue number | 2 II |
DOIs | |
State | Published - Aug 1996 |
ASJC Scopus subject areas
- Dermatology